Upregulation of VEGF-A without angiogenesis in a mouse model of dilated cardiomyopathy caused by mitochondrial dysfunction

Journal of Histochemistry and Cytochemistry

Volumn 50, Issue 7, 2002, Pages 935-944

  Tham, Emma ^a   Wang, Jianming ^a   Piehl, Fredrik ^a   Weber, Günther ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Angiogenesis; Angiopoietin; Dilated cardiomyopathy; HIF1 ; In situ hybridization; Mitochondria; VEGF

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEART DILATATION; HEART MITOCHONDRION; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KNOCKOUT MOUSE; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY CHAIN; WESTERN BLOTTING;

ANIMALIA;

EID: 0036065151     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540205000707     Document Type: Article

References (38)

1. Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy
2. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy
3. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
4. Molecular mechanisms of blood vessel formation
5. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development
6. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
7. Cellular oxygen sensing by mitochondria: Old questions, new insight
8. The angiopoietins: Yin and yang in angiogenesis
9. Molecular and functional aspects of PECAM-1/CD31
10. Mitochondria and heart disease
11. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences
12. Vascular endothelial growth factor: Molecular and biological aspects
13. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
14. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
15. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia
16. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1
17. Identification of an oxygen responsive enhancer element in the glyceral-dehyde-3-phosphate dehydrogenase gene
18. Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state
19. Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy
20. Novel molecular mechanism of increased myocardial endothelin-1 expression in the failing heart involving the transcriptional factor hypoxia-inducible factor-1alpha induced for impaired myocardial energy metabolism
21. Expression of the VEGF-related factor gene in pre- and postnatal mouse
22. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
23. Expression of nonclassical MHC class I (RT1-U) in certain neuronal populations of the central nervous system
24. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer
25. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
26. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors
27. Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain
28. Functions of Tiel and Tie2 receptor tyrosine kinases in vascular development
29. Fibroblast growth factors regulate calcitonin gene-related peptide mRNA expression in rat motoneurons after lesion and in culture
30. Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy
31. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies
32. The in vivo activity of vascular endothelial growth factor isoforms in the avian embryo
33. Platelet/endothelial cell adhesion molecule-1 (PECAM-1) is localized over the entire plasma membrane of endothelial cells
34. Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration
35. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
36. Vascular endothelial growth factor and basic fibroblast growth factor differentially modulate early postnatal coronary angiogenesis
37. Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression
38. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression